TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies.

Leo Luznik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.